What are the potential side effects of creatine for women? For most healthy women at standard doses, the likely effects are mild and short lived: gut discomfort, especially after a large single dose, and a small rise in scale weight from water stored inside muscle. The effects many women worry about most, kidney damage and hair loss, are not supported by the women-specific trial evidence. That does not mean creatine is risk free for everyone. It means the honest side effect list is shorter, and more boring, than the internet version, with clear gaps where the evidence runs out, notably pregnancy, breastfeeding and pre-existing kidney disease.

This article answers the safety question directly, rather than repeating the benefits case from yesterday. Yesterday we covered what creatine can do for women, and found modest strength and lean mass gains mainly in postmenopausal women who trained while taking at least 5 grams a day. This is the companion piece: what can go wrong, how often it actually happened in trials in women, and which fears rest on studies that never tested women at all.

What the women-specific safety evidence actually shows

The best starting point is a systematic review and meta-analysis that looked only at adverse outcomes in females taking oral creatine monohydrate. De Guingand and colleagues, writing in Nutrients in 2020, screened hundreds of studies and found 29 that monitored adverse outcomes in women, covering 951 participants. Their headline finding is reassuring but needs its exact wording. There were no deaths and no serious adverse outcomes reported. There were no significant differences between creatine and placebo in total adverse events, with a risk ratio of 1.24 and a 95 percent confidence interval from 0.51 to 2.98, in gastrointestinal events, with a risk ratio of 1.09 and a confidence interval from 0.53 to 2.24, or in weight gain, with a mean difference of 1.24 kilograms before the intervention and 1.37 kilograms after it, both with confidence intervals that crossed zero. No statistically significant difference was reported in measures of kidney or liver function.

Read those intervals carefully, because they are the difference between honest reporting and hype. A confidence interval that runs from 0.51 to 2.98 does not prove that creatine and placebo are identical. It means the pooled trials were too small and too varied to rule out a moderate difference in either direction. What the review does establish is that no large, consistent safety signal appeared across 29 studies, and that serious harm did not show up at all. That is a strong result for a supplement, and it is not the same as a guarantee for any individual woman.

The same pattern appears in the newest women-only evidence. A 2026 systematic review and meta-analysis in the Journal of the International Society of Sports Nutrition pooled seven randomised, placebo controlled trials in postmenopausal women only, covering 608 randomised women with a mean age of about 62 years and durations from 12 to 104 weeks, with a median of 38 weeks. Its safety conclusion was plain: adverse events were mild and similar to placebo, and renal indices were unchanged. The review rated safety outcomes as high certainty for its population, while noting that most trials carried some concerns about risk of bias and that the review was not prospectively registered. Again, the evidence is good but not perfect, and it is strongest for postmenopausal women, not for every woman at every life stage.

One more pooled figure helps put the whole picture in scale. The 2026 review cites a recent analysis of 685 randomised controlled trials including over 26,000 participants, which found no difference in overall side effect rates between creatine and placebo, at 4.60 percent versus 4.21 percent, with a p value of 0.828, and no individual adverse event significantly more common with creatine. That analysis covers mixed populations, not women only, so it is supporting evidence rather than a women-specific verdict. Still, it explains why researchers keep describing creatine as well tolerated: when trials count adverse events properly, creatine rarely separates from placebo at all.

1. Gut symptoms: the most likely real side effect

If creatine is going to bother you, the most likely way is through your stomach. Diarrhoea, bloating, nausea and general gut discomfort are the complaints that show up most reliably across studies, and they tend to be dose dependent. The clearest trial on this point followed athletes taking creatine for 28 days. One group took 10 grams a day as two 5 gram doses, another took 10 grams as a single dose, and a third took a placebo. Diarrhoea was reported by 28.6 percent of players taking two 5 gram doses and by 55.6 percent of players taking one 10 gram dose. The likely explanation is osmotic: when a large single dose is not fully absorbed, part of it stays in the intestine, draws water into the gut lumen and speeds up transit.

Two cautions belong with that striking comparison. First, the participants were soccer players, not a women-only sample, so the exact percentages should not be pasted onto women as if they were measured in women. Second, the trial is about a 10 gram single dose, which is double the usual daily maintenance dose. It is evidence against slamming a large scoop at once, not evidence that a standard 3 to 5 gram daily dose routinely causes gut problems.

A smaller, more recent study points the same way and shows why symptom counting matters. In a 28 day single blind randomised trial in 24 healthy male and female adults, one group took 5 grams a day and the other took a 20 gram a day loading dose for 14 days followed by 5 grams a day. All participants completed the study without any serious adverse events. One non-serious adverse event, menstrual cramps, was reported and deemed unrelated to creatine use. Undesired gastrointestinal symptoms were reported by 79.2 percent of all participants and by 81.0 percent of females, with bloating, water retention, puffiness and stomach discomfort most frequently cited. A higher proportion of participants in the loading group reported symptoms, and rated them as more severe, though the difference did not reach statistical significance.

That 79 percent figure looks alarming until you understand what was counted. A prompted symptom questionnaire that asks about every mild twinge will always return a higher rate than a trial that counts only adverse events reported spontaneously. This study is also a preprint, with only 24 participants, so it should not outweigh the meta-analyses above. Its value is practical: it confirms that mild gut and puffiness symptoms are common when people are asked closely, that loading makes them more likely, and that none of them were serious in this small trial. If your stomach acts up on creatine, the first moves supported by the evidence are to skip any loading phase, split the daily amount, take it with food and water, and make sure the powder is fully dissolved. If symptoms persist, stop and reassess rather than pushing through.

The 2026 postmenopausal review adds a women-specific detail that fits this picture. In a one year trial, mild gastrointestinal symptoms were slightly more common with creatine, at 5 versus 0, and muscle cramping occurred in 2 versus 0. Considered together, these events reached statistical significance. All events were self limited, none prompted withdrawal, and no study reported kidney impairment or discontinuation due to laboratory abnormalities. In other words, the women-specific trials found the same mild gut signal, at low absolute numbers, with no serious consequences.

2. Water weight and bloating: two different things

Bloating is the word that causes the most confusion in creatine discussions, because it is used for two different things. The first is water stored inside muscle cells. Creatine draws water into muscle along with creatine itself, and that can add weight to the scale. The 2026 postmenopausal review notes that creatine users typically accrue about 0.5 to 1.0 kilograms acutely, mainly from water retention during the first week. In the trials it pooled, weight changes paralleled gains in lean mass, and none of the included older women reported unwanted weight gain. Several viewed the increase as a positive indicator of muscle.

The female-only safety review tells a consistent story with wider uncertainty. Weight gain in the creatine group averaged about 1.2 to 1.4 kilograms, similar to what is seen in male studies, but the difference versus placebo was not statistically significant. That matters for expectations. If you start creatine and the scale rises by about a kilogram in the first weeks while your waist measurement stays steady, that is most plausibly muscle water, not fat gain. No trial in women reported fat mass increases attributable to creatine. If your goal is purely a lower scale number, that early rise can still be unwelcome, and it is a legitimate reason to decide creatine is not for you. It is not evidence that creatine makes women gain fat.

The second kind of bloating is gut bloating: a feeling of fullness, gas or pressure in the stomach. That is a digestive symptom, covered in the previous section, and it behaves differently. Muscle water is not felt as a swollen belly, and gut bloating is not a sign that muscle water is building up. Keeping the two apart stops a lot of unnecessary worry, and it explains why two women can both say creatine made them bloated while describing completely different experiences.

3. Kidneys: the lab quirk every woman should know

Kidney damage is the most persistent creatine fear, and it is the one with the clearest answer in healthy adults. The International Society of Sports Nutrition position stand on creatine, published in 2017, concluded that there is no compelling evidence that creatine supplementation negatively affects renal function in healthy individuals. The 2026 postmenopausal review points the same way for its population: renal indices were unchanged, and no study reported renal impairment. In a two year trial, creatinine rose by about 5 micromoles per litre in both the creatine and placebo groups, likely due to ageing, with no difference between groups and values remaining within normal ranges.

There is one laboratory quirk that every woman taking creatine should know before a blood test. Creatine breaks down into creatinine, so blood creatinine can rise while kidney filtration itself is unchanged. That matters because creatinine is the marker most routine kidney tests use to estimate filtration. A modest creatinine rise on creatine is an expected consequence of processing more creatine, not proof of kidney injury on its own. Tell your clinician you take creatine before blood work, so a raised creatinine is interpreted in context, and so that a more direct filtration measure can be used if there is genuine doubt.

The limit of this reassurance is just as clear. Evidence for safety in people with pre-existing kidney disease remains very limited, and reviews consistently describe that gap as an important limitation. The position stand conclusion covers otherwise healthy individuals, and the women-specific reviews studied healthy or generally well postmenopausal women, not women with kidney disease. If you have kidney disease, reduced kidney function, or a condition that affects the kidneys, creatine is a clinician conversation first, not a self-experiment. The same applies if you take regular medication that affects kidney function: the trial data does not give you a personal all clear.

4. Cramps and dehydration: a myth that got it backwards

Muscle cramps and dehydration are often listed as creatine side effects, but controlled studies do not support that listing. A systematic review with meta-analyses found no evidence that creatine hinders the body’s ability to regulate heat or disrupts fluid balance, and controlled trials of athletes exercising in the heat reported no adverse effects at recommended doses. Creatine increases total and intracellular body water, which, if anything, supports thermoregulation rather than undermining it.

One often cited study even found the opposite of the myth. In collegiate football players, creatine users experienced fewer cramps, fewer cases of heat illness or dehydration, less muscle tightness, fewer muscle strains and fewer total injuries compared with non-users. That study was in male collegiate athletes, so it cannot be quoted as a women-specific finding, and it was not a randomised trial designed to test cramps as its primary outcome. Its role here is narrower: it shows that the cramp claim, which began as anecdote, has not survived controlled testing, and in one athletic population the association ran the other way.

What about the cramping reported in the one year postmenopausal trial, at 2 versus 0? That is a real, small signal, and it is included above rather than hidden. Two cases in one trial, with no withdrawals and no pattern across the other trials, do not overturn the broader finding. They do mean that if you develop new, persistent cramping after starting creatine, you should stop, check hydration and electrolytes with a clinician if needed, and not assume the supplement is innocent simply because trials found no overall effect.

5. Hair loss: one small study in men, no hair ever measured

Hair loss is the side effect that worries many women most, and it is the one with the weakest foundation. Almost every warning traces back to a single 2009 study from Stellenbosch University, published in the Clinical Journal of Sport Medicine. Twenty college-aged rugby players, all men, took creatine for three weeks: a loading phase of 25 grams a day for seven days, followed by a maintenance dose of 5 grams a day for two weeks. Dihydrotestosterone, or DHT, a hormone linked to pattern hair loss, rose by roughly 56 percent above baseline after the loading week and remained about 40 percent above baseline after the maintenance phase, while total testosterone did not change significantly. DHT values stayed within the normal laboratory range.

The crucial detail is what the study did not do. It never measured a single hair. Nobody counted follicles, graded scalps or tracked shedding. The link to baldness was an extrapolation by readers, not a finding of the paper. In the years since, that DHT result has not been cleanly reproduced, and broader reviews of creatine and hormones find no consistent, meaningful effect on testosterone or DHT. A 2025 randomised controlled trial that assessed hair directly over 12 weeks, using phototrichogram measurement, found no DHT rise and no change in hair density between creatine and placebo. That trial was in resistance-trained men, so it does not directly settle the question for women, but it removes the only direct hair evidence that existed, and it leaves the original mechanism claim without a replication.

For women specifically, the position is therefore precise rather than comforting in a vague way. No women-only trial has established creatine as a cause of hair loss. No trial has measured hair loss as an outcome in women taking creatine. The entire scare rests on a hormone change in 20 young men, within the normal range, with no hair outcome at all. That is not proof that no woman will ever shed more hair while taking creatine, since hair shedding has many causes and trials rarely track it closely. It is proof that hair loss should not be presented as a known side effect of creatine for women. If you notice increased shedding after starting any supplement, the useful step is to check other causes with a clinician, including iron, thyroid, stress, illness and hair care changes, rather than assuming the creatine mechanism is proven.

6. Hormones, periods and masculinisation: what is not in the evidence

Two related worries deserve a direct answer because they shape how women think about creatine. The first is masculinisation: will creatine make a woman bulky or masculine? Creatine does not contain hormones, and reviews find no consistent effect on testosterone or related hormones. The average lean mass gains in women-only trials were modest, under half a kilogram over months of training, and the muscle that follows creatine comes from training, protein intake and time, not from the powder. Nothing in the women-specific trials supports a masculinising effect.

The second is menstrual disruption. No women-specific trial reviewed here reported menstrual disruption as a creatine effect. The one mention of menstrual cramps in the small 28 day trial above was a single non-serious event deemed unrelated to creatine use. That single case proves nothing in either direction, and it would be wrong to cite it as evidence for or against an effect. The fair summary is that menstrual effects are not an established side effect, and they are also not an outcome that trials have tracked systematically. If your cycle changes after starting creatine, that is worth raising with a clinician, because cycle changes have many causes and deserve attention on their own merits, not because creatine is a proven culprit.

The same logic applies to liver damage, which is sometimes listed alongside kidney damage in supplement warnings. The female-only safety review found no statistically significant difference in liver function measures between creatine and placebo groups. The postmenopausal review, which monitored renal and liver function markers over two years, found no clinically significant differences. Liver harm is not a signal in the women-specific trial data.

7. Who should pause and ask a clinician first

The safety case for creatine is strong for healthy adults, and it stops at the edge of the studied population. Four groups sit outside that population, and for them the correct advice is to pause and ask, not to assume the general reassurance applies.

First, women who are pregnant. The female-only safety review explicitly covered post-pubertal, non-pregnant females, so it carries no reassurance about pregnancy. Human trials of creatine supplementation in pregnancy are lacking, and reviewers describe the human evidence as limited with risk unknown. Animal work on creatine and fetal neuroprotection is interesting, but animal work is not a safety trial in pregnant women, and it should never be quoted as one.

Second, women who are breastfeeding. The NIH lactation reference LactMed advises avoiding creatine supplements while breastfeeding unless a healthcare professional prescribes them, because milk levels after supplementation have not been measured in humans. Creatine is naturally present in breast milk, especially in colostrum, but natural presence is not the same as safety of a supplement dose, and nobody has measured how much transfers after a mother supplements. Until that measurement exists, caution is the evidence-based position, not alarmism.

Third, women with kidney disease or reduced kidney function, and women taking regular medication that affects the kidneys. The trial evidence in this group is very limited, and the reassuring conclusions are explicitly framed for otherwise healthy individuals. A clinician who knows your kidney function and medication list is the right person to weigh this, not a general article.

Fourth, anyone under 18, and anyone buying a product that is not what its label claims. Supplement quality is a separate risk from the creatine molecule itself. Plain creatine monohydrate is the form used in almost all the research, and third party tested products reduce the risk of contamination or hidden ingredients. A blend that hides its dose, bundles stimulants, or makes hormone claims is not the intervention the trials tested, and its side effects cannot be predicted from the creatine literature.

8. A lower risk protocol if you decide to try it

For a healthy adult woman who decides to test creatine, the trial evidence points to a simple, low risk version of the protocol. Use plain creatine monohydrate, at 3 to 5 grams a day, with no loading phase. Loading saturates muscle faster, but it is optional, and it is the phase most linked to gut symptoms and early water weight gain. Taking 3 to 5 grams daily saturates muscle over about four weeks, which is fine for a 12 week self-experiment judged on strength and measurements rather than daily scale readings.

Split the dose if your stomach is sensitive, take it with food and water, and dissolve the powder fully. Pair it with resistance training two to three times a week, because the women-specific trials that found gains combined creatine with training, and trials without training showed no measurable effect. Track the right things for eight to 12 weeks: your main lifts, repetitions at a fixed weight, waist and hip measurements, body weight trend rather than daily spikes, sleep, and any gut symptoms. Tell your clinician you take creatine before blood tests, so a creatinine rise is read in context.

Stop rules matter more than start rules. Stop and reassess if gut symptoms persist beyond the first adjustment, if you develop new cramping that does not resolve, if you notice hair shedding that concerns you, or if any new medical issue arises while you are taking it. A supplement that does nothing for you, or that you tolerate poorly, is not worth continuing out of habit. The trials suggest a modest training aid for women who train, not a product worth enduring side effects for.

Frequently asked questions

What are the most common side effects of creatine for women?

Mild gut symptoms such as diarrhoea, bloating and stomach discomfort, especially after a large single dose or a loading phase, and a small rise in scale weight from water stored inside muscle. In women-specific trials, adverse events were mild and similar to placebo, with no serious adverse events attributable to creatine.

Does creatine damage the kidneys in women?

In healthy women, trials found no kidney impairment and no difference in renal indices versus placebo. Blood creatinine can rise because creatine breaks down into creatinine, which is not the same as kidney damage. Evidence in pre-existing kidney disease is very limited, so get medical advice first in that case.

Does creatine cause hair loss in women?

No women-only trial has established that. The scare comes from one 2009 study in 20 young male rugby players, where DHT rose within the normal range and hair was never measured. A later 12 week trial that measured hair directly found no change, though it was in men. Hair loss is not a proven side effect of creatine for women.

Will creatine make a woman gain fat or look bulky?

No trial in women reported fat mass increases attributable to creatine. Scale weight may rise by about 0.5 to 1.0 kilograms in the first week from muscle water, and by about 1.2 to 1.4 kilograms on average in the female-only safety review, with the difference versus placebo not statistically significant. Creatine does not contain hormones and does not raise testosterone to male levels.

Is creatine safe while pregnant or breastfeeding?

Safety has not been established in either case. The female-only safety review excluded pregnant women, human pregnancy trials are lacking, and LactMed advises avoiding creatine supplements while breastfeeding unless a healthcare professional prescribes them, because milk levels after supplementation have not been measured. Ask a clinician rather than relying on general reassurance.

Should I do a loading phase?

Loading is optional and it is the phase most linked to gut symptoms. A standard 3 to 5 gram daily dose saturates muscle over about four weeks without the higher single doses that cause most stomach upset. If your stomach is sensitive, skip loading, split the dose, and take it with food and water.

Sources

• Naddafha et al., Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis, Journal of the International Society of Sports Nutrition, 2026. PubMed record and full text at PMC.
• De Guingand et al., Risk of adverse outcomes in females taking oral creatine monohydrate: a systematic review and meta-analysis, Nutrients, 2020. DOI 10.3390/nu12061780.
• Kreider et al., International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine, Journal of the International Society of Sports Nutrition, 2017. DOI 10.1186/s12970-017-0173-z.
• Antonio et al., Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?, Journal of the International Society of Sports Nutrition, 2021. DOI 10.1186/s12970-021-00412-w.
• Van der Merwe, Brooks and Myburgh, Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players, Clinical Journal of Sport Medicine, 2009. PubMed record.
• Ostojic and Ahmetovic, Gastrointestinal distress after creatine supplementation in athletes: are side effects dose dependent?, Research in Sports Medicine, 2008. DOI 10.1080/15438620701693280.
• Kreider et al., Safety of creatine supplementation: analysis of adverse events reported in clinical trials and adverse event reports, Journal of the International Society of Sports Nutrition, 2025. DOI 10.1080/15502783.2025.2533690.

Related reading

• Is Creatine Good for Females? What the Evidence Says: the benefits companion to this safety guide, from the same week-of-2-November question list.
• Can You Gain Muscle From Creatine Without Exercise? What the 12-Week Trial Found: what 10 grams a day did in sedentary adults aged 45 to 65, with the water weight caveat.
• Does Creatine Help Your Brain on a Sleepless Night? What 29 Sleep-Deprived Adults Showed: the acute brain trial, and why its large single dose is not a lifestyle dose.